Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siegbert Rieg

Showing results (151-160 of 164) with videos related to

Pageof 17
Sort By:
Nature Medicine|November 13, 2020
Characterization of pre-existing and induced SARS-CoV-2-specific CD8<sup>+</sup> T cellsIsabel Schulien, Janine Kemming, Valerie Oberhardt, et al.
European Journal of Neurology|August 19, 2021
Neurological symptoms and complications in predominantly hospitalized COVID-19 patients: Results of the European multinational Lean European Open Survey on SARS-Infected Patients (LEOSS)Nina N Kleineberg, Samuel Knauss, Eileen Gülke, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 25, 2022
Impact of adherence to individual quality-of-care indicators on the prognosis of bloodstream infection due to Staphylococcus aureus: a prospective observational multicentre cohortFrancesc Escrihuela-Vidal, Achim J Kaasch, Maja Von Cube, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 24, 2024
S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis) - Part 1: Diagnosis, initial management, and immunomodulating systemic therapyRuben Heuer, Maren Paulmann, Thorsten Annecke, et al.
Infection|October 1, 2020
First results of the "Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)"Carolin E M Jakob, Stefan Borgmann, Fazilet Duygu, et al.
Eclinicalmedicine|July 9, 2025
Identification and validation of clinical phenotypes in <i>Staphylococcus aureus</i> bloodstream infection and their association with mortality (FEN-AUREUS study)Belén Gutiérrez-Gutiérrez, Belén Gallego-Mesa, Achim J Kaasch, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 17, 2024
S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis) - Part 2: Supportive therapy of EN in the acute and post-acute stagesMaren Paulmann, Ruben Heuer, Thorsten Annecke, et al.
Frontiers in Medicine|March 21, 2024
The protective effect of tumor necrosis factor-alpha inhibitors in COVID-19 in patients with inflammatory rheumatic diseases compared to the general population-A comparison of two German registriesRebecca Hasseli, Frank Hanses, Melanie Stecher, et al.
Biomedicines|October 27, 2022
COVID-19 Severity and Thrombo-Inflammatory Response Linked to EthnicityBeate Heissig, Yousef Salama, Roman Iakoubov, et al.
The Lancet. Infectious Diseases|January 20, 2024
Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trialAchim J Kaasch, Luis Eduardo López-Cortés, Jesús Rodríguez-Baño, et al.
Pageof 17

Showing results (151-160 of 164) with videos related to

Sort By:
Pageof 17
Nature Medicine|November 13, 2020
Characterization of pre-existing and induced SARS-CoV-2-specific CD8<sup>+</sup> T cellsIsabel Schulien, Janine Kemming, Valerie Oberhardt, et al.
European Journal of Neurology|August 19, 2021
Neurological symptoms and complications in predominantly hospitalized COVID-19 patients: Results of the European multinational Lean European Open Survey on SARS-Infected Patients (LEOSS)Nina N Kleineberg, Samuel Knauss, Eileen Gülke, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 25, 2022
Impact of adherence to individual quality-of-care indicators on the prognosis of bloodstream infection due to Staphylococcus aureus: a prospective observational multicentre cohortFrancesc Escrihuela-Vidal, Achim J Kaasch, Maja Von Cube, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 24, 2024
S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis) - Part 1: Diagnosis, initial management, and immunomodulating systemic therapyRuben Heuer, Maren Paulmann, Thorsten Annecke, et al.
Infection|October 1, 2020
First results of the "Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)"Carolin E M Jakob, Stefan Borgmann, Fazilet Duygu, et al.
Eclinicalmedicine|July 9, 2025
Identification and validation of clinical phenotypes in <i>Staphylococcus aureus</i> bloodstream infection and their association with mortality (FEN-AUREUS study)Belén Gutiérrez-Gutiérrez, Belén Gallego-Mesa, Achim J Kaasch, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 17, 2024
S3 guideline: Diagnosis and treatment of epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis) - Part 2: Supportive therapy of EN in the acute and post-acute stagesMaren Paulmann, Ruben Heuer, Thorsten Annecke, et al.
Frontiers in Medicine|March 21, 2024
The protective effect of tumor necrosis factor-alpha inhibitors in COVID-19 in patients with inflammatory rheumatic diseases compared to the general population-A comparison of two German registriesRebecca Hasseli, Frank Hanses, Melanie Stecher, et al.
Biomedicines|October 27, 2022
COVID-19 Severity and Thrombo-Inflammatory Response Linked to EthnicityBeate Heissig, Yousef Salama, Roman Iakoubov, et al.
The Lancet. Infectious Diseases|January 20, 2024
Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trialAchim J Kaasch, Luis Eduardo López-Cortés, Jesús Rodríguez-Baño, et al.
Pageof 17